SCHEMBL4644725

SCHEMBL4644725

O=C(O)c1ccc(C(Cl)(Cl)Cl)c(C(Cl)(Cl)Cl)c1C(Cl)(Cl)Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
ALDH1A1 P00352 8/20 0.39
TSHR P16473 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CASP1 P29466 1/20 0.36
ALOX15 P16050 1/20 0.36
SELL P14151 1/20 0.34
SELP P16109 1/20 0.34
KDM4E B2RXH2 4/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
HSD17B10 Q99714 2/20 0.33
CA12 O43570 2/20 0.33
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33
CA14 Q9ULX7 2/20 0.33
HAAO P46952 1/20 0.33
DAO P14920 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4645833 0.82 TSHR (0.48) CYP1A2ALDH1A1TSHRSMN1; SMN2ALOX15
SCHEMBL2109549 0.74 ALDH1A1 (0.58) CYP1A2ALDH1A1TSHRSMN1; SMN2ALOX15
SCHEMBL3367799 0.71 ALDH1A1 (0.43) CYP1A2ALDH1A1TSHRSMN1; SMN2CASP1
SCHEMBL27589790 0.71 HAAO (0.38) CYP1A2ALDH1A1TSHRHAAODAO
Hydrochloric Acid SCHEMBL11858933 0.69 TSHR (0.59) CYP1A2ALDH1A1TSHRSMN1; SMN2ALOX15
SCHEMBL19115961 0.67 EPHX2 (0.33) CYP1A2ALDH1A1TSHRSMN1; SMN2CASP1
SCHEMBL6236049 0.67 CYP1A2 (0.41) CYP1A2ALDH1A1TSHRALOX15SELL
SCHEMBL4643432 0.67 CYP1A2 (0.41) CYP1A2ALDH1A1TSHRSMN1; SMN2CASP1
SCHEMBL4647359 0.67 ALDH1A1 (0.43) CYP1A2ALDH1A1ALOX15KDM4EHSD17B10
SCHEMBL4942021 0.66 CYP1A2 (0.50) CYP1A2ALDH1A1TSHRSMN1; SMN2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1443042-B1 HYBRID ONIUM SALT WAKO PURE CHEM IND LTD (JP) 2008-08-13 EP disclosed
US-7101918-B2 Hybrid type onium salt WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2006-09-05 US disclosed
US-7049464-B2 Process for producing of an aminoalkylsulfonic acid and a method of salt exchange for a salt thereof WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2006-05-23 US disclosed
US-20050261370-A1 Process for producing of an aminoalkylsulfonic acid and a method of salt exchange for a salt thereof WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2005-11-24 US disclosed
EP-1548002-A1 PROCESS FOR PRODUCING AMINOALKYLSULFONIC ACID AND METHOD OF SALT EXCHANGE FOR SALT THEREOF Wako Pure Chemical Industries, Ltd. (JP) 2005-06-29 EP disclosed
US-20050054677-A1 Process for preparing amine-substituted benzofurans KU YI-YIN (US) 2005-03-10 US disclosed
US-20050020710-A1 Hybrid onium salt WAKO PURE CHEMICALS INDUSTRIES, LTD. (JP) 2005-01-27 US disclosed
US-6822101-B2 REACTING 1-(3-BUTYNYL)-PYRROLIDINE OR -PIPERIDINE WITH PHENOLIC COMPOUND; CYCLIZATION; TREATING WITH BORONIC ACID DERIVATIVE; HISTAMINE-3 RECEPTOR LIGANDS ABBOTT LABORATORIES 2004-11-23 US disclosed
EP-1443042-A1 HYBRID ONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2004-08-04 EP disclosed
US-20040133007-A1 Process for preparing amine-substituted benzofurans ABBOTT LABORATORIES 2004-07-08 US disclosed
WO-2004024707-A2 PROCESS FOR PREPARING AMINE TYPE SUBSTITUTED BENZOFURANS ABBOTT LABORATORIES (US) 2004-03-25 WO disclosed
US-20040054185-A1 Process for preparing amine-substituted benzofurans COWART MARLON D (US) 2004-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261370-A1 Process for producing of an aminoalkylsulfonic acid and a method of salt exchange for a salt thereof ARSA, ADSL, ASS1 CYP1A2 959/4885ALDH1A1 623/4885TSHR 2671/4885
US-20050054677-A1 Process for preparing amine-substituted benzofurans HRH4, HRH2, HRH3 CYP1A2 629/4885ALDH1A1 1468/4885TSHR 915/4885
US-20040133007-A1 Process for preparing amine-substituted benzofurans HRH4, HRH2, HRH3 CYP1A2 578/4885ALDH1A1 1563/4885TSHR 951/4885
US-20040054185-A1 Process for preparing amine-substituted benzofurans HRH4, HRH2, HRH3 CYP1A2 578/4885ALDH1A1 1563/4885TSHR 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.